BindingDB PrimarySearch

Found 14 hits of ki for monomerid = 189434
Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	k_off s^-1	k_on M^-1s^-1	pH	Temp °C
Coagulation factor VII (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.430	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FVIIa-Xase Ki (37� C.): S2765 (0.5 mM), PCPS (25 μM), calcium chloride (5 mM), full-length human TF (3 nM), human FVIIa (5 pM), and FVIIa inhibi...				US Patent US9174974 (2015) BindingDB Entry DOI: 10.7270/Q2W37V32
Bristol-Myers Squibb Company US Patent					More data for this Ligand-Target Pair
Coagulation factor VII/Tissue factor (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	0.430	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of full-length human TF/recombinant human factor 7a assessed as decrease in conversion of factor 10 to factor 10a by measuring S2765 hydro...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Vitamin K-dependent protein C (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	190	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human activated protein C using pyroGlu-Pro-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric ...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	520	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human plasma kallikrein using H-(D)-Pro-Phe-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric ...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Coagulation factor VII (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	650	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Tissue kallikrein-1 (37� C) activity was determined in reactions containing 0.05 nM enzyme and 90 μM substrate (H-D-Val-Leu-Arg-AFC) in buffer (...				US Patent US9174974 (2015) BindingDB Entry DOI: 10.7270/Q2W37V32
Bristol-Myers Squibb Company US Patent					More data for this Ligand-Target Pair
Kallikrein-1 (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	650	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human HK1 using H-D-Val-Leu-Arg-AFC as substrate assessed as release of AFC after 10 to 120 mins by spectrofluorimetric method				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.50E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human plasmin using H-(D)-Val-Leu-LyspNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric method				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Coagulation factor IX (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.60E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human factor 9a using methylsulfonyl-D-cyclohexylglycyl-Gly-Arg-AMC as substrate assessed as release of AMC after 10 to 120 mins by spe...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	3.40E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human factor 11a using pyroGlu-Pro-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric method				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Coagulation factor X (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	4.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human factor 10a using N-benzoyl-Ile-Glu-(OH,OMe)-Gly-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectroph...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Coagulation factor XII (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	7.50E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human factor 12a using H-(D)-CHT-Gly-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric method				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Tissue-type plasminogen activator (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	9.10E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human recombinant tPA using methylsulfonyl-D-cyclohexylalanylGly-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins b...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.10E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of alpha-thrombin (unknown origin) using pyroGlu-Pro-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotom...				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM189434 (US9174974, Example 19) Show SMILES Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb R&D Curated by ChEMBL					Assay Description Inhibition of human urokinase using pyro-Glu-Gly-Arg-pNA as substrate assessed as release of pNA after 10 to 120 mins by spectrophotometric method				J Med Chem 59: 7125-37 (2016) Article DOI: 10.1021/acs.jmedchem.6b00469 BindingDB Entry DOI: 10.7270/Q2TM7D37
Bristol-Myers Squibb R&D Curated by ChEMBL					More data for this Ligand-Target Pair